TARSUS PHARMACEUTICALS INC
TARS·87650L103·US·Common Stock·Healthcare - Biotechnology-13D/G
TARS (TARSUS PHARMACEUTICALS INC) is held by 144 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($249.2M), RTW INVESTMENTS, LP ($234.7M), Janus Henderson Group Ltd. ($157.2M). Net institutional sentiment: Mixed.
144
Holders
Avg rating(25 Elite)
$2.3B
Total Value
53% (154)
Fund Consensus
78 buying - 68 selling
Who's Trading
InsiderARAzamian Bobak R.Sell $281KJun 17, 2026
InsiderARAzamian Bobak R.Sell $335KJun 17, 2026
InsiderGKGoodrich KatherineSell $183KJun 15, 2026
ActivistDTDeep Track Capital, LP8.5%May 15, 2026
InsiderPIPYOTT DAVID E IExercise 1K shApr 24, 2026
InsiderNSNeervannan SeshadriSell $200KMar 20, 2026
13F: Insider & Congress:
Showing 1-20 of 154
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer